Rarity Bioscience - Reach the full potential of MRD
ESH 2023 Conference
Anna Robelius, Specialist in Hematology at Akademiska Hospital, will present the poster Utility of Blood vs Bone marrow for Molecular MRD in AML and MDS.
In the study, patients samples that previously been analysed using NGS and ddPCR mutation assays, has been re-analyzed using the Rarity Bioscience’s ultra-sensitive superRCA mutation assays, comparing blood and bone marrow. Anna Robelius will go into detail of the results when presenting the poster at the conference.
Meet Rarity Bioscience at the ESH 2023 Conference ”Acute Myeloid Leukemia ’Molecular and Translational’: Advances in Biology and Treatment” in Estoril, Portugal 29-31 of October.